China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Progress in Major Asset Restructuring

Aug 29, 2026 · Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Progress in Major Asset Restructuring

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from China Resources Double-crane Pharmaceutical Co., Ltd. Class A

"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on the Profit Distribution Plan for the First Half of 2026Aug 22
"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on the Obtaining of the Drug Registration Certificate for Lidocaine Hydrochloride GelAug 19
"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration Certificate for Sodium Lactate Ringer's Irrigation Solution by Wholly-owned Subsidiary Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd.Aug 14

All China Resources Double-crane Pharmaceutical Co., Ltd. Class A news releases